AstraZeneca Sues Andrx Over Tropol-XL Patent
The U.K.-Swedish drug maker said it filed the suit after Andrx submitted a Paragraph IV Certification letter letter indicating its intention to manufacture and sell metoprolol succinate in the 50 mg dose form in the U.S.
Metoprolol succinate is marketed as Toprol-XL in the United States by AstraZeneca. In 2003, TOPROL-XL...
To view the full article, register now.